Previous studies have demonstrated that lncRNA NR2F1-AS1 can influence breast and gastric cancer progression by activating insulin-like growth factor-1 (IGF-1)/IGF-1R/ERK [20], MAP3K2 [30], and AKT3 [31], which crosstalk with AKT. Here, AKT1 is linked to gastric cancer.